✦ LIBER ✦

W1814 Safety and Tolerability of 96 Weeks of Tenofovir Disoproxil Fumarate (TDF) Treatment in HBeAg Negative and Positive Patients Infected with Chronic Hepatitis B (CHB)

✍ Scribed by Jacobson, Ira M.; Marcellin, Patrick; Heathcote, Jenny; Mathurin, Philippe; Gane, Ed J.; Buggisch, Peter; Husa, Petr; Krastev, Zahary; Sorbel, Jeff; Anderson, Jane; Mondou, Elsa; Rousseau, Franck

Book ID: 122497385
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 144 KB
Volume: 136
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(09)64000-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

925 SAFETY AND TOLERABILITY OF 96 WEEKS

925 SAFETY AND TOLERABILITY OF 96 WEEKS OF TENOFOVIR DISOPROXIL FUMARATE (TDF) TREATMENT IN HBeAg NEGATIVE AND POSITIVE PATIENTS INFECTED WITH CHRONIC HEPATITIS B (CHB)

✍ P. Marcellin; E.J. Heathcote; I. Jacobson; P. Mathurin; E. Gane; P. Buggisch; P. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 161 KB

20 THREE YEARS OF TENOFOVIR DISOPROXIL F

20 THREE YEARS OF TENOFOVIR DISOPROXIL FUMARATE (TDF) TREATMENT IN HBEAG-NEGATIVE AND POSITIVE PATIENTS WITH CHRONIC HEPATITIS B (STUDY 102 AND STUDY 103)

✍ M. Rizzetto; P. Marcellin; E.J. Heathcote; J. Sorbel; E. Mondou; J. Anderson; F. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 58 KB

559 COST-EFFECTIVENESS SIMULATION ANALYS

559 COST-EFFECTIVENESS SIMULATION ANALYSIS OF TENOFOVIR DISOPROXIL FUMARATE (TENOFOVIR) IN HBEAG NEGATIVE (-) PATIENTS WITH CHRONIC HEPATITIS-B (CHB) IN ITALY AND FRANCE

✍ B. Deniz; F. Everhard 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 54 KB

57 TENOFOVIR DISOPROXIL FUMARATE (TDF) F

57 TENOFOVIR DISOPROXIL FUMARATE (TDF) FOR THE TREATMENT OF HBEAG-NEGATIVE CHRONIC HEPATITIS B: WEEK 72 TDF DATA AND WEEK 24 ADEFOVIR DIPIVOXIL SWITCH DATA (STUDY 102)

✍ P. Marcellin; I. Jacobson; F. Habersetzer; H. Senturk; P. Andreone; C. Moyes; A. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 59 KB

72 TENOFOVIR DISOPROXIL FUMARATE (TDF) F

72 TENOFOVIR DISOPROXIL FUMARATE (TDF) FOR THE TREATMENT OF HBEAG-POSITIVE CHRONIC HEPATITIS B: WEEK 72 TDF DATA AND WEEK 24 ADEFOVIR DIPIVOXIL SWITCH DATA (STUDY 103)

✍ J. Heathcote; J. George; S. Gordon; J.P. Bronowicki; J. Sperl; R. Williams; P. M 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 58 KB

254 Tenofovir Disoproxil Fumarate (TDF)

254 Tenofovir Disoproxil Fumarate (TDF) for the Treatment of HBeAg-Positive Chronic Hepatitis B: Week 72 TDF Data and Week 24 Adefovir Dipivoxil Switch Data (Study 103)

✍ Heathcote, Jenny; George, Jacob; Gordon, Stuart C.; Bronowicki, Jean-Pierre; Spe 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 66 KB